Contact Us

Have an inquiry? Please send us a message.

         

123 Street Avenue, City Town, 99999

(123) 555-6789

email@address.com

 

You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

News

News from Elf, a digital creative agency at the intersection of the arts and sciences.

Filtering by Tag: CDC

No Protection Still for Pets and Animals From Covid-19 Infection

Elf

© Grahm S. Jones/Columbus Zoo and Aquarium. Jupiter was a 14-year-old Amur tiger.

Despite the passage of time, no Covid-19 vaccine has been developed for animals. Currently, animals can contract Covid-19 through humans. Most pets that develop Covid-19 get it directly from contact with infected human owners. Please be careful if you have any animal pets or friends.

Learn more from the CDC here: https://www.cdc.gov/healthypets/covid-19/pets.html

Will Covid-19 Become Endemic?

Elf

The World Health Organization (WHO) has said that vaccinations and natural immunity acquired through infection, will eventually lead to “stabilization and normalization. This means that Covid-19 would not be eradicated completely but become “endemic” or regularly found among people similar to the flu.

While omicron has been contagious, it has been less disruptive than prior Covid-19 mutant strains such as the Delta variant, which has offered hope that future waves of infection would not require lockdowns. Omicron has however put a large strain on hospital systems. The federal government has offered free Covid-19 test kits and N95 masks to combat the surge. Self-reported Covid-19 cases have increased by over 25 percent to 57 million in the last few days of December through January 10, according to Bloomberg. Prior estimates by the CDC indicated an expected increase and peak in omicron infections in January and then stabilization. Vigilance and increased vaccination has been encouraged by the federal government and WHO to lower transmission and the development of further variants.

FDA Offers Emergency Use Authorization For Two Vaccines to Combat Covid-19

Elf

The FDA approved emergency use of two vaccines, one by Pfizer and one by Moderna to combat Covid-19

covid-vaccine-web-824x549.jpg

Pfizer and Moderna Vaccines to Prevent Covid-19

With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day.
— Stephen M. Hahn, M.D and FDA Commissioner

On Dec 11, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a vaccine to prevent the coronavirus disease 2019 (COVID-19) that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) . The vaccine is approved for use in individuals aged 16 years of age and older. This emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine, manufactured by the pharmaceuticals company Pfizer Inc. to be distributed in the U.S.

A week later, the FDA also approved an EUA for the vaccine developed by Moderna, another pharmaceutical company. The Moderna COVID-19 Vaccine contains messenger RNA (mRNA), which is genetic material. The vaccine contains a small piece of the SARS-CoV-2 virus’s mRNA that instructs cells in the body to make the virus’s distinctive “spike” protein. After a person receives this vaccine, their body produces copies of the spike protein, which does not cause disease, but instead, triggers the immune system to learn to react defensively, producing and developing an immune response against SARS-CoV-2.

While approving emergency use of both vaccines, the FDA also warned that the FDA does not have any FDA-approved vaccines and that taking this vaccine, while recommended, may not protect everyone. Still the clinical success rates are much higher than standard issue vaccines that hover around 70%. Clinical trials had initially shown a 95% success rate for the Pfizer vaccine and 94.1% success rate for the Moderna vaccine, giving researchers more confidence in recommending the vaccine for use.

Both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine are administered as a 2-dose series, 3 weeks apart, into the muscle.

Covid-19 Symptoms

COVID-19 disease is caused by a coronavirus called SARS-CoV-2, which has not been seen before. You can get COVID-19 through contact with another person who has the virus. Primarily a respiratory illness that can affect other organs, COVID-19 has results in varying symptoms in people from mild to severe illness. Symptoms do not appear immediately showing up 14 days after infection or exposure. Symptoms can include any of the following: fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; and diarrhea.


Side Effects of Taking a Vaccine

After receiving a second dosage of the vaccine, some recipients have reported side effects such as pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, and fever.

More information is available on the FDA’s website and via this Pfizer PDF download and Moderna PDF download.

More data on the clinical trials are available at the New England Journal of Medicine.